QSQuantSignals Research/Studies
Try FST free

← All studies

FAIL

Out-of-the-money option wings bought before FDA PDUFA decisions

If you buy the 0.20-delta call, the 0.20-delta put, or both three sessions before a PDUFA date and sell after the decision, does the premium pay after costs?

No. All three pre-registered structures lost money after costs. The 0.20-delta strangle lost 50.0% of premium on average over 721 events (median -97.1%; one-sided 95% lower bound -56.5%); the 0.20-delta call wing lost 55.1% over 726 (median -100%; lower bound -66.4%); the 0.20-delta put wing lost 46.4% over 734 (median -100%; lower bound -54.5%). Skew was positive (4.62, 7.21, 5.46) and every structure had at least 30 tradeable events, but the mean and its lower bound were far below zero, so all three fail. The descriptive core check points the same way: on the 753 events with the needed quotes, the at-the-money straddle's median implied move at entry was 14.7% against a median realised move of 7.2%, and realised exceeded implied on only 26.4% of them. Options priced a bigger move than the decision delivered, even for complete response letters (median implied 28.8%, realised 18.4%), so buying these wings was not cheap.

Backtested by QS Research

Pre-registration

Written before any event list or option or stock price was read, and amended once before any result. Events are US-listed common stocks with a PDUFA date announced at least five sessions ahead, from January 2018; the pre-registration called for one row per announcement, with a trade using the latest PDUFA date known at entry, but the frozen list, committed at 830 rows before pricing, is one row per ticker and PDUFA date and each trade uses the date in its own row (see limitations). Three structures are each a trial: buy the 0.20-delta call and put (strangle), the call only, or the put only, three sessions before the date at the ask. The expiry is the first listed expiry at least two sessions after the date. Exit is at the bid on the first close after the decision filing, or at intrinsic if no decision is found by expiry. Costs are $0.0065 a share on each fill; returns are per $1 of premium. A structure passes only if the mean return after costs is above zero, the one-sided 95% lower bound of a 10,000-draw bootstrap clustered by PDUFA month is above zero, skew is positive and there are at least 30 tradeable events. Three trials are counted; there is no holdout. Amendment 1 added a delta diagnostic and two exploratory variants with no pass verdict.

Registered 2026-10-29

Amendments

Trials · 3 trials · 0 passed · judged at N = 3 trials; 2965 trials run in total

TrialVerdict
(a) long strangle (~0.20-delta call AND put)FAILcounted
(b) call wing only (~0.20-delta call)FAILcounted
(c) put wing only (~0.20-delta put)FAILcounted

Limitations

The numbers: every trial's checks, metrics, curve and yearly results, and the provenance

1 published version · current 2a3f56025454d8c7, published 2026-11-21

Put these signals to work

This page is free. Members get the live version of every QS Research signal. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans